LANTERN PHARMA
A Sections 8 and 15 combined declaration has been accepted and acknowledged.Word Mark
•
Never miss important updates for LANTERN PHARMA
Get instant alerts when status changes, similar marks are filed, or renewal deadlines approach
Key Information
Ownership
LP
Owner Name
Address
Dallas, TX 75201
Critical Dates
First Use Date
Jan 1, 2017
Filing Date
Sep 11, 2019
Registration Date
Jan 28, 2020
Mark Descriptions
Services
Class 42
drug discovery services; pharmaceutical research and development services in the field of oncology; pharmaceutical drug discovery services in the field of oncology; scientific and medical research and development for pharmaceuticals, pharmaceutical preparations and substances in the field of oncology
Mark Elements
Text Mark
LANTERN PHARMA
Category
Service mark
Standard Characters
Yes
Color Claim
No
Trademark Timeline
First Use
Filing Date
Publication Date
Registration Date
USPTO Records
No documents found for this trademark.